1.
Distinct Radiomic Phenotypes Define Glioblastoma TP53-PTEN-EGFR Mutational Landscape
by Zinn, Pascal O
Neurosurgery, 2017-09-01, Vol.64 (CN_suppl_1), p.203-210
2.
Imaging Genomic Mapping in Glioblastoma
by Zinn, Pascal O
Neurosurgery, 2013-08-01, Vol.60 (CN_suppl_1), p.126-130
3.
138 Diffusion MRI ADC Mapping of Glioblastoma Edema/Tumor Invasion and Associated Gene Signatures
by Zinn, Pascal O
Neurosurgery, 2015-08-01, Vol.62 (CN_suppl_1), p.210-210
4.
Diffusion Weighted Magnetic Resonance Imaging Radiophenotypes and Associated Molecular Pathways in Glioblastoma
by Zinn, Pascal O
Neurosurgery, 2016-08-01, Vol.63 (CN_suppl_1), p.127-135
5.
334 A Functional Screen Identifies miRNAs that Induce Radioresistance in Glioblastomas
by Chen, Clark C
Neurosurgery, 2016-08-01, Vol.63 (CN_suppl_1), p.197-198
6.
139 Clinically Applicable and Biologically Validated MRI Radiomic Test Method Predicts Glioblastoma Genomic Landscape and Survival
by Zinn, Pascal O
Neurosurgery, 2016-08-01, Vol.63 (CN_suppl_1), p.156-157
7.
188 Radiogenomic Mapping of MRI-FLAIR-Phenotypes Identifies a Novel Gene-microRNA Regulatory Axis to Target Glioblastoma Invasion
by Zinn, Pascal O
Neurosurgery, 2012-08-01, Vol.71 (2), p.E573-E573
8.
222 Dexamethasone Induces Mesenchymal Trans-differentiation and Promotes Hallmarks of Cancer in Glioblastoma
by Zinn, Pascal O
Neurosurgery, 2017-09-01, Vol.64 (CN_suppl_1), p.260-261
